Common questions you may have about SUSTOL

You’re bound to have questions when learning about a new treatment. Speaking with your healthcare provider is the best way to get all of the information you need. In the meantime, here are some answers to questions that you may have about SUSTOL.

What is SUSTOL?

SUSTOL is a prescription medicine called an “antiemetic.” SUSTOL is used in adults to help prevent the nausea and vomiting that happens right away or later with certain anticancer medicines (chemotherapy). It is different from other antiemetics. After being injected under the skin, it slowly releases medication to prevent nausea and vomiting.1,2

How does SUSTOL help?

SUSTOL is designed to be injected under the skin to slowly release medication over time. This design is why SUSTOL can help provide a full 5 days of protection.2

Why did my healthcare provider prescribe SUSTOL?

Up to 80% of patients may experience chemotherapy-induced nausea and vomiting after receiving treatment.3 That is why you were prescribed SUSTOL.

When will I get SUSTOL?

Your healthcare professional will inject SUSTOL about 30 minutes before you receive your anticancer medicine (chemotherapy).1

What side effects can I expect with SUSTOL?

The most common side effects of SUSTOL include injection site reactions, constipation, fatigue, headache, diarrhea, stomach-area (abdominal) pain, trouble sleeping or falling asleep, indigestion, dizziness, weakness, and heartburn.1

These are not all the possible side effects of SUSTOL. Tell your healthcare provider if you have any side effect that bothers you or does not go away.1

Is SUSTOL expensive?

SUSTOL is covered under most insurance plans for patients who qualify. If you have commercial insurance, you may be eligible for a $0 copay,* and SUSTOL may also be provided at no cost to eligible patients who need financial assistance. For more information, call Heron Connect® Patient Services at 1-844-HERON11 (1-844-437-6611).

What if I have more questions about SUSTOL?

If you have other questions about SUSTOL, ask your healthcare professional or call Heron Connect® Patient Services at 1-844-HERON11 (1-844-437-6611).

  • Limitations apply. Offer not valid as follows: (a) patients covered under Medicare, Medicaid, or any federal or state program; (b) where plan covers treatment for the patient for the entire cost of the prescription drug. Patients pay $0 per copay per dose per 12-month calendar period. During the eligibility period, the out-of-pocket drug expenses for CINVANTI® (aprepitant) injectable emulsion and/or SUSTOL will be covered up to $80 per CINVANTI (aprepitant) treatment or $160 per SUSTOL (granisetron) treatment. When applicable, deductible assistance up to $200 per treatment will be covered. For cash paying patients, the program will cover $150 per prescription up to $1,800 per benefit cap per calendar year. Eligibility for the copay assistance is for 12 months, after which the patient will need to reapply for continued assistance.
  • Heron Therapeutics reserves the right, at its sole discretion, to discontinue the Heron Connect Patient Assistance Program or change the qualifications at any time. All patient information remains confidential. Product supply for the program depends upon availability.

References:

  1. SUSTOL [prescribing information]. Heron Therapeutics, Inc., 2023.
  2. Ottoboni, et al. J Exp Pharmacol. 2014.
  3. National Cancer Institute. Nausea and vomiting related to cancer treatment (PDQ®)—health professional version. Accessed August 3, 2023. Updated July 20, 2023. www.cancer.gov/about-cancer/treatment/side-effects/nausea/nausea-hp-pdq.